On December 2, 2016, JHL Biotech, Inc. (GTSM:6540) closed the transaction. The company issued 28,415,111 shares for gross proceeds of TWD 2,557,360. The shares were issued at a premium of TWD 0.09 per share. The securities issued are subject to hold period of three years.